Research progress on STAT protein inhibitors in the treatment of lymphoma / 药学学报
Acta Pharmaceutica Sinica
; (12): 703-710, 2021.
Article
in Zh
| WPRIM
| ID: wpr-876537
Responsible library:
WPRO
ABSTRACT
The abnormal activation and mutation of signal transducer and activator transcription (STAT) proteins has been implicated in multiple lymphomas. The research discovery and clinical application of STATs inhibitors have become an important strategy for treating lymphoma. This review introduces the abnormal activation and mutation of STATs in multiple malignant lymphomas, and focuses on reviewing the latest screening strategies targeting STATs and its clinical application in the treatment of lymphoma, providing references for the further development of STATs inhibitors.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Acta Pharmaceutica Sinica
Year:
2021
Type:
Article